High levels of circulating triiodothyronine induce plasma cell differentiation

Journal of Endocrinology

Volumn 220, Issue 3, 2014, Pages 305-317

  Bloise, Flavia Fonseca ^a   de Oliveira, Felipe Leite ^a   Nobrega, Alberto Félix ^a   Vasconcellos, Rita ^b   Cordeiro, Aline ^a   de Paiva, Luciana Souza ^a,b   Taub, Dennis D ^c,d   Borojevic, Radovan ^a   Pazos Moura, Carmen Cabanelas ^a   de Mello Coelho, Valéria ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B lymphocyte; Bone marrow; Hyperthyroidism; Plasma cell; Spleen; Thyroid hormone

Indexed keywords

B LYMPHOCYTE; BONE MARROW; HYPERTHYROIDISM; PLASMA CELL; SPLEEN; THYROID HORMONE;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; FEMALE; HUMANS; HYPERTHYROIDISM; IMMUNOGLOBULINS; MALE; MICE; MICE, INBRED C57BL; PLASMA CELLS; SPLEEN; THYROXINE; TRIIODOTHYRONINE;

EID: 84894382269     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0315     Document Type: Article

References (56)

1. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA & Hardy RR 2001 Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. Journal of Immunology 167 6834-6840.
2. 3Ra2 gene deletion on T and B lymphocyte development. Journal of Immunology 164 152-160.
3. Bahn RS, Burch HB, CooperDS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA et al. 2011 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocrine Practice 17 456-520. (doi:10.4158/EP.17.3.456)
4. Baldridge CW,amp; Peterson FR 1927 Splenic enlargement in hyperthyroidism. Journal of the American Medical Association 88 1701-1702. (doi:10.1001/jama.1927.02680480011006)
5. Bianco AC 2011 Minireview: Cracking the metabolic code for thyroid hormone signaling. Endocrinology 152 3306-3311. (doi:10.1210/en.2011-1104)
6. Burrows PD, Stephan RP, Wang YH, Lassoued K, Zhang Z & Cooper MD 2002 The transient expression of pre-B cell receptors governs B cell development. Seminars in Immunology 14 343-349. (doi:10.1016/S1044-5323(02)00067-2)
7. Celik I, Akalin S & Erbas T 1995 Serum levels of interleukin 6 and tumor necrosis factor-a in hyperthyroid patients before and after propylthiouracil treatment. European Journal of Endocrinology 132 668-672. (doi:10.1530/eje.0.1320668)
8. Chan OT, Madaio MP & Shlomchik MJ 1999 B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. Journal of Immunology 163 3592-3596.
9. Dahlberg PA, Petrick PA, Nissim M, Menezes-Ferreira MM &Weintraub BD 1987 Intrinsic bioactivity of thyrotropin in human serum is inversely correlated with thyroid hormone concentrations. Application of a new bioassay using the FRTL-5 rat thyroid cell strain. Journal of Clinical Investigation 79 1388-1394. (doi:10.1172/JCI112966)
10. De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB & Davis PJ 2011 Thyroid hormones as modulators of immune activities at the cellular level. Thyroid 21 879-890. (doi:10.1089/thy.2010.0429)
11. Fabris N 1973 Immunodepression in thyroid-deprived animals. Clinical and Experimental Immunology 15 601-611.
12. Fairfax KA, Kallies A, Nutt SL & Tarlinton DM 2008 Plasma cell development: from B-cell subsets to long-termsurvival niches. Seminars in Immunology 20 49-58. (doi:10.1016/j.smim.2007.12.002)
13. Foster MP, Montecino-Rodriguez E & Dorshkind K 1999 Proliferation of bone marrow pro-B cells is dependent on stimulation by the pituitary/thyroid axis. Journal of Immunology 163 5883-5890.
14. Gronwall C, Vas J & Silverman GJ 2012 Protective roles of natural IgM antibodies. Frontiers in Immunology 3 66. (doi:10.3389/fimmu.2012.00066)
15. Hardy RR & Hayakawa K 2001 B cell development pathways.Annual Review of Immunology 19 595-621.(doi:10.1146/annurev.immunol.19.1.595)
16. Hardy RR, Carmack CE, Shinton SA, Kemp JD & Hayakawa K 1991 Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.Journal of Experimental Medicine 173 1213-1225.(doi:10.1084/jem.173.5.1213)
17. Hastings ML, Milcarek C, Martincic K, Peterson ML & Munroe SH 1997 Expression of the thyroid hormone receptor gene, erbAa, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels.Nucleic Acids Research 25 4296-4300.(doi:10.1093/nar/25.21.4296)
18. Hou X, Li Y, Li J, Wang W, Fan C,Wang H, Zhang H, Shan Z & TengW2011 Development of thyroid dysfunction and autoantibodies in Graves' multiplex families: an eight-year follow-up study in Chinese Han pedigrees.Thyroid 21 1353-1358.(doi:10.1089/thy.2011.0035)
19. Hu L, Dixit VD, de Mello-Coelho V & Taub DD 2004 Age-associated alterations in CXCL1 chemokine expression by murine B cells.BMC Immunology 5 15.(doi:10.1186/1471-2172-5-15)
20. Ioos V, Das V, Maury E, Baudel JL, Guechot J, Guidet B & Offenstadt G 2008 A thyrotoxicosis outbreak due to dietary pills in Paris.Therapeutics and Clinical Risk Management 4 1375-1379.
21. Jones TH, Kennedy RL, Justice SK & Davies R 1997 Effect of glucocorticoids and oestrogen on interleukin-6 production by human thyrocytes from patients with Graves' disease and toxic multinodular goitre and from HTori3 cells.European Journal of Endocrinology 137 429-432.(doi:10.1530/eje.0.1370429)
22. Justement LB 2001 The role of the protein tyrosine phosphatase CD45 in regulation of B lymphocyte activation.International Reviews of Immunology 20 713-738.(doi:10.3109/08830180109045587)
23. Kallies A, Hasbold J, Tarlinton DM, DietrichW, Corcoran LM, Hodgkin PD & Nutt SL 2004 Plasma cell ontogeny defined by quantitative changes in Blimp-1 expression.Journal of Experimental Medicine 200 967-977.(doi:10.1084/jem.20040973)
24. Klecha AJ, Barreiro Arcos ML, Genaro AM, Gorelik G, Silberman DM, Caro R & Cremaschi GA 2005 Different mitogen-mediated b-adrenergic receptor modulation in murine T lymphocytes depending on the thyroid status.Neuroimmunomodulation 12 92-99.(doi:10.1159/000083581)
25. Klecha AJ, Genaro AM, Gorelik G, Barreiro Arcos ML, Silberman DM, SchumanM, Garcia SI, Pirola C & Cremaschi GA 2006 Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway.Journal of Endocrinology 189 45-55.(doi:10.1677/joe.1.06137)
26. Klein U & Dalla-Favera R 2007 Unexpected steps in plasma-cell differentiation.Immunity 26 543-544.(doi:10.1016/j.immuni.2007.05.005)
27. Korholz D, Gerdau S, Enczmann J, Zessack N & Burdach S 1992 Interleukin 6-induced differentiation of a human B cell line into IgM-secreting plasma cells is mediated by c-fos.European Journal of Immunology 22 607-610.(doi:10.1002/eji.1830220248)
28. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G & Torring O 2008 TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.European Journal of Endocrinology 158 69-75.(doi:10.1530/EJE-07-0450)
29. Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, Torres R, Lamers MC & Carsetti R 1999 B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.Journal of Experimental Medicine 190 75-89.(doi:10.1084/jem.190.1.75)
30. Lokmic Z, Lammermann T, SixtM, Cardell S, Hallmann R & Sorokin L 2008 The extracellular matrix of the spleen as a potential organizer of immune cell compartments.Seminars in Immunology 20 4-13.(doi:10.1016/j.smim.2007.12.009)
31. Ludgate M 2000 Animal models of Graves' disease.European Journal of Endocrinology 142 1-8.(doi:10.1530/eje.0.1420001)
32. Mebius RE & Kraal G 2005 Structure and function of the spleen.Nature Reviews.Immunology 5 606-616.(doi:10.1038/nri1669)
33. Mei HE, Schmidt S & Dorner T 2012 Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity.Arthritis Research & Therapy 14(Suppl 5) S1.(doi:10.1186/ar3909)
34. Montaudouin C, Anson M, Hao Y, Duncker SV, Fernandez T, Gaudin E, Ehrenstein M, Kerr WG, Colle JH, Bruhns P et al.2013 Quorum sensing contributes to activated IgM-secreting B cell homeostasis.Journal of Immunology 190 106-114.(doi:10.4049/jimmunol.1200907)
35. Montecino-Rodriguez E, Leathers H,amp; Dorshkind K 2006 Identification of a B-1 B cell-specified progenitor.Nature Immunology 7 293-301.(doi:10.1038/ni1301)
36. Nakano H, Yanagita M & Gunn MD 2001 CD11cCB220CGr-1C cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.Journal of Experimental Medicine 194 1171-1178.(doi:10.1084/jem.194.8.1171)
37. Nijnik A, Pistolic J, Wyatt A, Tam S & Hancock RE 2009 Human cathelicidin peptide LL-37 modulates the effects of IFN-g on APCs.Journal of Immunology 183 5788-5798.(doi:10.4049/jimmunol.0901491)
38. Ohye H, Fukata S, Kanoh M, Kubota S, Kuma K, Miyauchi A & Sugawara M 2005 Thyrotoxicosis caused by weight-reducing herbal medicines.Archives of Internal Medicine 165 831-834.(doi:10.1001/archinte.165.8.831)
39. Oliveira KJ, Ortiga-Carvalho TM, Cabanelas A, Veiga MA, Aoki K, Ohki- Hamazaki H, Wada K, Wada E & Pazos-Moura CC 2006 Disruption of neuromedin B receptor gene results in dysregulation of the pituitary- thyroid axis.Journal of Molecular Endocrinology 36 73-80.(doi:10.1677/jme.1.01892)
40. Ouchida R, Mori H, Hase K, Takatsu H, Kurosaki T, Tokuhisa T, Ohno H & Wang JY 2012 Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses.PNAS 109 E2699-E2706.(doi:10.1073/pnas.1210706109)
41. Paavonen T 1982 Enhancement of human B lymphocyte differentiation in vitro by thyroid hormone.Scandinavian Journal of Immunology 15 211-215.(doi:10.1111/j.1365-3083.1982.tb00640.x)
42. Pedro AB, Romaldini JH & Takei K 2011 Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.Neuroimmunomodulation 18 45-51.(doi:10.1159/000311519)
43. Persani L 1998 Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity.Thyroid 8 941-946.(doi:10.1089/thy.1998.8.941)
44. Pillai S & Cariappa A 2009 The follicular versus marginal zone B lymphocyte cell fate decision.Nature Reviews.Immunology 9 767-777.(doi:10.1038/nri2656)
45. Pontikides N & Krassas GE 2007 Basic endocrine products of adipose tissue in states of thyroid dysfunction.Thyroid 17 421-431.(doi:10.1089/thy.2007.0016)
46. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T & Hiepe F 2006 Competence and competition: the challenge of becoming a long-lived plasma cell.Nature Reviews.Immunology 6 741-750.(doi:10.1038/nri1886)
47. Renno T, Attinger A, Rimoldi D, Hahne M, Tschopp J & MacDonald HR 1998 Expression of B220 on activated T cell blasts precedes apoptosis.European Journal of Immunology 28 540-547.(doi:10.1002/(SICI) 1521-4141(199802)28:02!540::AID-IMMU540O3.0.CO;2-Y)
48. Ribeiro-Carvalho MM, Smaniotto S, Neves-dos-Santos S, Mouco T, Savino W & Mello-Coelho V 2007 Triiodothyronine modulates differential homing of recent thymic emigrants to peripheral lymphoid organs.Scandinavian Journal of Immunology 66 8-16.(doi:10.1111/j.1365-3083.2007.01910.x)
49. Shahrara S, Drvota V & Sylven C 1999 Organ specific expression of thyroid hormone receptor mRNA and protein in different human tissues.Biological & Pharmaceutical Bulletin 22 1027-1033.(doi:10.1248/bpb.22.1027)
50. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL & Weigert MG 1987 The role of clonal selection and somatic mutation in autoimmunity.Nature 328 805-811.(doi:10.1038/328805a0)
51. Su YW, Hao Z, Hirao A, Yamamoto K, Lin WJ, Young A, Duncan GS, Yoshida H, Wakeham A, Lang PA et al.2011 14-3-3s regulates B-cell homeostasis through stabilization of FOXO1.PNAS 108 1555-1560.(doi:10.1073/pnas.1017729108)
52. Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K,amp; Mozai T 1988 Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.Journal of Clinical Endocrinology and Metabolism 66 147-152.(doi:10.1210/jcem-66-1-147)
53. Tokoyoda K, Hauser AE, Nakayama T & Radbruch A 2010 Organization of immunological memory by bone marrow stroma.Nature Reviews.Immunology 10 193-200.(doi:10.1038/nri2727)
54. Ueki I, Abiru N, Kobayashi M, Nakahara M, Ichikawa T, Eguchi K & Nagayama Y 2011 B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.Clinical and Experimental Immunology 163 309-317.(doi:10.1111/j.1365-2249.2010.04301.x)
55. Walfish PG 1976 Triiodothyronine and thyroxine interrelationships in health and disease.Canadian Medical Association Journal 115 338-342.Ye M & Graf T 2007 Early decisions in lymphoid development.Current Opinion in Immunology 19 123-128.(doi:10.1016/j.coi.2007.02.007)
56. Ye M & Graf T 2007 Early decisions in lymphoid development.Current Opinion in Immunology 19 123-128.(doi:10.1016/j.coi.2007.02.007)